Walsh Deina H's Form 4 filing
Bone Biologics Corp (BBLG) · filed Sep 7, 2023
- Accession no.
- 0001493152-23-031935
- Filed
- Sep 7, 2023
- Trade date
- Sep 6, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $4.97K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Walsh Deina HCIK 0001651572 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 6, 2023 | Common Stock | PPurchaseAcquired | +300 | $0.70 | +$210 | 300 | Direct | |
| Sep 6, 2023 | Common Stock | PPurchaseAcquired | +6,700 | $0.71 | +$4,757 | 7,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.